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Chromosomal translocations constitute important diagnostic markers in many
different forms of neoplasia and are coming under increased scrutiny for their pos-
sible role in the development and progression of a variety of human tumors. The
molecular events leading to chromosomal translocation are at present unknown. How-
ever, in principle, chromosomal translocations may be conceptualized as arising by
two general types of mechanisms. Breakage and rejoining of DNA could take place
at random sites by illegitimate, interchromosomal recombination. On the otherhand,
certain sites in DNA may be predisposed to recombine in certain cells or under cer-
tain conditions.
Because translocations in lymphoid tumors often show a chromosomal breakpoint
located within a normally rearranging antigen receptor gene, it has been suggested
that the lymphocyte recombinase might catalyze chromosomal breakage and rejoining
(1). This model predicts the presence of heptamer/nonamer-like recombinase rec-
ognition sequences in the DNA adjoining the breakpoints of both participating chro-
mosomes, although only one of the breakpoints lies within a normally rearranging
locus. However, in previously analyzed cases of translocations involving Ig (2-8),
TCR-a (9, 10), -S (11, 12), and -/3 (13, 14) loci, sequences with convincing similarity
to the heptamer/nonamer consensus sequence have only sporadically been found
adjoining the breakpoint of the participating non-antigen receptor locus. Even when
heptamer/nonamer-like sequences have been found near translocation breakpoints,
the significance ofthesesequences has been difficult to evaluate because most studies
have been limited to descriptions of breakpoints in single cases. Furthermore, previous
studies of breakpoint sequences have generally not examined the reciprocal product
breakpoints, thereby leaving the exact site of initial chromosomal breakage ambig-
uous. With these considerations in mind, we have performed sequence analyses of
chromosomal breakpoints of both recombination products in several examples of
the recurrent translocation t(7 ;9) (g34;g32), recently described in human T cell neo-
plasms (13).
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Materials and Methods
Cell Lines and Tissues.
￿
The TALL cell lines SUP-T3 and SUP-T5, showing the t(7;9)
(g34;g32), were maintained in culture as described (15). Both show concordance with the
original tumor biopsy samples from which they were derived, as assessed by karyotyping
andby Southern blot analysis usingOTCR J-region probes. Thethird case, BT, is not repre-
sented by a cell line. The source of DNA from this case was a tumor biopsy sample from
the involved bone marrow of a patient with TALL.
DNA Probes.
￿
The origins of DNA fragment hybridization probes are shown in Fig. 1.
The R.5 probe is a 0.5-kb Rsa I fragment derived from chromosome 9 DNA and located
100 by 5' oftheder(9) SupT3 breakpoint. TheA.5 probe is a0.5-kbAva II/Hind III fragment
derived from chromosome 9 DNA located 3 kb 3' of theder(7) breakpoint. Both probes were
subcloned from the appropriate phage clones into Puc 18 or Puc 19 vectors. TheCol probe,
used in the initial phase of cloning, consists of a 3.5-kb Hind III fragment containing con-
stant region sequence oftheCol segment of the TCR-Rgene which strongly cross-hybridizes
to the C/02 segment (16).
Phage Cloning.
￿
Construction and screeningof phagelibraries wascarried out by standard
methods (17). The der(9) SUP-T3 clonewas obtained by ligating Bam HI-digested SUPT3
DNA, size-selected to encompass each oftwo TCR(3 gene rearrangements detected on Southern
blots, into XEMBL3A arms and screening the resultingphage libraries with the C(31 probe.
Two clones were obtained, each corresponding to oneof the twoTCR0 gene rearrangements.
Both clones were restriction mapped and then sequenced in the region 5' to and including
theJ02 cluster. One clone proved to represent a normal, potentially productive, OTCR re-
arrangement. The second, Xder(9)SUPT3, showed chromosome 9 DNAjuxtaposed 5' toJ02.3
(13). To obtain germline chromosome 9 DNA spanning the translocation breakpoint region,
probe R.5,derived from this clone, was used to screen alibrary ofsize-selected human sperm
DNA fragments ligated into the Eco RI site ofphage X607. This screeningproduced a phage
clone AGL9 from which the probe A.5 was isolated. This probe in turn was used to screen
alibrary ofsize-selected DNA fragments from SUP-T3 ligated into the Hind III site of phage
X590 to obtain Xder(7)SUPT3, whichcontainedthebreakpoint region of thereciprocal product
of the translocation. The der(9) and der(7) breakpoint regions of the two additional cases
were isolated in asimilarfashion from X590 size-selectedgenomiclibraries ofleukemia DNA,
yielding phage clones Xder(9)SUPT5, Xder(7)SUPT5, Xder(9)BT, and Xder(7)BT. Restric-
tion mapping of all phage clones was carried out after subcloning of phage inserts into Puc
18 or Puc 19 plasmid vectors.
DNA Sequencing
￿
Appropriate DNA restriction fragments were subcloned into M13 phage
vectors and their sequence determined by the dideoxy chain-termination method (18). In
some cases specific synthetic oligonucleotides were used as sequencing primers.
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Results and Discussion
Analysis of the Chromosomal Breakpoints in the 1(7;9) Translocation of the SURT3 Cell
Line. The t(7;9) (g34;g32) chromosomal translocation is carried by the established
TALL cell line SUPT3 (13), the first cell line or tumorfound to contain this translo-
cation. Since chromosomal band 7834 is the cytologic locus of the TCR-0 gene, we
reasoned that the translocation breakpoint might be amenable to molecular cloning
by screening an appropriate genomic phage library with a TCR(3 probe. Starting
from this assumption, we cloned DNA spanning the breakpoint in the der(9) trans-
location product from this cell line. A DNA probe (probe R.5) subcloned from this
DNA was confirmed to derive from chromosome 9 by hybridization to Southern
blots ofDNA from a panel of CHO/human hybrid cell lines containingisolated human
chromosomes (13). Probe R.5 was also used to isolate from human sperm a DNA
fragment that contained the region of the germline chromosome 9 split by the trans-
location. A second probe (probe A.5) generated from the 3' end of the germline chro-
mosome 9 DNA fragment was used in turn to isolate from SUP-T3 cells a third DNA
fragment, which contained the breakpoint region of the reciprocal, or der(7) product
of the translocation. Comparison of the positions of restriction sites in these three
DNA fragments showed that the SUP-T3 translocation is probably balanced with
respect to chromosome 9 DNA (i .e., shows no evidence of deletions), although not
with respect to chromosome 7 DNA, from which deletion of some DNA had evi-
dently occurred (Fig. 1).
To establish the DNA sequence surrounding the exact site of breakage on chro-
mosomes 7 and 9, the relevant regions of the der(9), der(7), and germline chromo-
some 9 DNA clones were sequenced. Alignment of these sequences (Fig. 2) confirmed
that the translocation is balanced with respect to chromosome 9, but not with re-
spect to chromosome 7 . In the der(9) product chromosome 9 DNA is juxtaposed
5' to J02.3 while in the der(7) product chromosome 9 DNA is juxtaposed 3' to se-
quence identifiable as TCR-(3 variable and diversity gene segments in the form of
a V(3-DO1.1 joint . The VR gene shows strong sequence similarities with published
Vs cDNA sequences (19, 20). Chromosome 7 DNA which originally lay between
the Do1.1 segment and J02 .3 has been deleted. The translocation therefore suggests
an abortive attempt at D01 .1J02.3 joining in which the DOU segment was mis-
takenlyjoined to chromosome 9 sequence, giving rise to the der(7), whileJO2 .3 was
mistakenlyjoined to chromosome 9 sequence, giving rise to the der(9) . The VO-Do
joint found upstream of the der(7) breakpoint may have been formed later, after
the translocation event but before outgrowth of the tumor clone represented in the
SUP-T3 cell line.
The germline chromosome 9 sequence which has been interrupted by the SUP-T3
translocation, as identified by sequence alignment (Fig. 2), shows two palindromic
heptamer sequences, CAC(A/T)GTG, in opposite orientations, separated by 7 bp.
Breakage has occurred between thesetwo sequences; the 5' heptamer is absent from
the der(7) product, while the 3' heptamer is absent from the der(9) product. The
chromosome 9 heptamer sequences perfectly match the canonical heptamer of the
conserved heptamer/nonamer recombination signal that flanks all known rearranging
antigen receptor gene segments (21). Evidence derived from both enzymatic in vitro
(22, 23) and functional in vivo (24) studies indicates that the lymphocyte recom-
binase apparatus specifically recognizes this sequence motif, and cuts DNA at the37 2
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boundaries ofthe heptamer sequences. Therefore, thestructureofthe SUPT3 trans-
location is consistent with atranslocation mechanism in which the lymphocyte recom-
binase has recognized both the"normal" or physiologic TCRf3 recombination signals
at chromosome 7834 and the "ectopic" heptamer signals at chromosome 9832. For-
mation of the der(9) product would result from utilization of signals flankingjfl2.3
and the 3' heptamer at chromosome 9g32, while formation of the der(7) product
could be enhanced by utilization of the signals flanking 1301.1 and the 5' heptamer
of 9g32 . The opposite relative orientations of the two chromosome 9 heptamers is
consistent with this model. The presence or absence of nonamer-like sequences is
of unclear importance, due to the poor conservation of these sequences within an-
tigenreceptor genes. However, an A/Trich 9-bp sequence is present in chromosome
9 DNA at the predicted location 12 by 5' to the 5' heptamer. In any event, observa-
tions in othersystems imply that a heptamer aloneis sufficient for recombinase rec-
ognition (25, 26).
Analyses ofthe ChromosomalBreakpoints in TwoAdditional Examples ofthe1(7;9) Translo-
cation. If the chromosome 9 paired heptamers are in fact specifically recognized
by the lymphocyte recombinase in the translocation mechanism, additional examples
of the t(7;9) (g34;g32) would be expected to show this same chromosome 9 break-
point. To investigate this hypothesis, we analyzed twoadditional casesofTALL which,TYCKO ET AL.
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on ourinitial screening of 22 cases, were found to show rearranged bandson Southern
blots hybridized with the chromosome 9 breakpoint probe R.5 (13). By a strategy
analogous to that used in cloning the SUP-T3 translocation products, we isolated
the breakpoint regions of both products from these two additional cases. The re-
strictionmaps ofDNA from the resultingphageclones, Xder(9)SUPT6, Ader(7)SUP-
T6, hder(9)BT, and Xder(7)BT, show agreementwith the maps of theSUP-T3 clones
in the regions consisting of chromosome 9 DNA (Fig. 1). DNA sequence in the vi-
cinities ofthebreakpoint in the four clones was analyzed, yielding results displayed
in Fig. 2. As predicted by the recombinase-mediated breakage model, examination
ofthetworeciprocal products in each case indicatesthat therearevariable N-insertions
and deletions, o£ the type characteristic of normal D-J joints, at the breakpoints of
all three cases. The N-insertions found at normal DJ joints are usually G/C rich
(21). This feature is also observed at the translocation breakpoints of at least two
of the three translocation cases.
The only featureofthe t(7;9) (g34;g32) breakpoints that is perhaps not a common
characteristic of normal DJ joints is the presence in the der(9) product from one
case (BT) of adeletion of 28 by from 5' chromosome 9 DNA. This deletion is some-
what longer than those usuallyfound in normal gene rearrangements and may have
resulted from a relative inefficiency of the recombinase-mediated re-ligation of the
translocation intermediates, allowing slightly more time for action by the putative
recombinase-associated exonuclease. Nevertheless, the der(7) product of theBT trans-
location does not show alarge deletion, nordo either of the translocation products
of the other two cases.
Most importantly, by comparing the sequences of the der(7) products with that
of the germline chromosome 9, all three cases show chromosome 9 breakpoints be-
tween the two consensus heptamers, within 2 by of each other. However, due to the
junctional modifications (removal and/or addition of nucleotides) which are typi-
cally associated with recombinase activity, it is not possible to exactly localize the
initial cleavage site. The sequence alignments (Fig. 2 A) place outside boundaries
on the region of initial endonucleolytic cleavage in each case. The actual cleavage
site could have occurred anywhere between the endpoints of the chromosome 9 se-
quences in the two reciprocal products in each case, followed by deletion of chromo-
some 9 sequences from the free ends before joining to chromosome 7 DNA.
The events inferred to underlie the translocation process differ somewhat from
normal antigen receptor gene rearrangement in several respects, for instance by in-
cluding two chromosomes (rather than just one), four free DNA ends (rather than
just two), and at least three endolytic cleavages (one in chromosome 9 and two in
chromosome 7, as opposed to just two cleavages during normal intrachromosomal
gene rearrangement). No direct evidence demonstrates that all of the cleavages and
ligations presumed to occur during translocation necessarily proceeded in a closely
coupled, concerted fashion, as they apparently do in normal gene rearrangements .
However, the repeated appearance of the same or similar sites in the translocation
products implies that all of the involved DNA regions areheld in some type of phys-
ical complex, probably associated with the recombinaseenzyme, during the translo-
cation process.
The lymphocyte recombinase normally produces joints whose structure is most
consistent with an initialdouble-stranded endonucleolytic attack; that is, direct repeats374
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characteristic ofstaggered single-stranded breakage are not found when the sequence
of the D-J joint is compared with that of the physiological reciprocal product con-
taining the fused heptamers (21, 27). In this regard the recombinase would appear
to differ from other prokaryotic and eukaryotic enzymes mediating general and site-
specific recombination, which produce short sequence duplications at sites of recom-
bination (28-30). Similar to sites of D-J joining, our sequence data show no dupli-
cated sequence (direct repeats) on comparison of der(9) and der(7) translocation
products in any of the three t(7;9) (g34;g32) cases studied by us .
Heptamer-like Sequences Are Variably Present at Breakpoints in Other Chromosomal Translo-
cations. Partial homologies to consensus heptamer sequences, usually less complete
than the homologies described here, have been found previously near breakpoints
in the chromosomal translocations of lymphoid neoplasms (2, 7, 9-14). Croce and
co-workers, as well as other investigators, have suggested the possible role of such
homologies in recombinase-mediated translocations involving antigen receptor genes
on one chromosome participating in the translocation (1, 2). However, besides the
limited homology of these sequences to canonical heptamer sequences, in most cases
previously analyzed, only one ofthe two translocation products was sequenced, leaving
the actual position of the breakpoint target site unclear.
In at least two specific common lymphoid tumor translocations there would ap-
pear to be contradictory evidence as to the role of recombinase-mediated breakage.
Several laboratories have analyzed breakpoints in the t(14;18) of B cell lymphoma
(3, 4), a type of translocation suggested by Croce and co-workers to represent an
example of recombinase-mediated breakage (1), and have found no well-conserved
heptamer-like sequences in the 150-bp major breakpoint cluster region (mbr). In-
deed, the wide scatter of breakpoints (3-5, 7, 31, 32) observed in this particular type
of translocation would seem, apriori, incompatible with strong recombinase-mediated
targeting. Furthermore, in the analysis of the der(14) and der(18) products in one
case, Bakhshi et al. found a trinucleotide direct repeat at the breakpoints of both
products (3). On this basis they proposed that recombinogenic random staggered
breaks determine the positions ofthe chromosome 18 breakpoints and that breakage
within the mbr is simply selected for based on the resulting activation or deregula-
tion of the bcl-2 gene. Some support for this alternative model is also provided by
a study of reciprocal products in t(12;15) translocations of murine plasmacytomas
(33). One of four c-myc breakpoints in these translocations showed a duplication of
target sequences, as did a single t(8;22) translocation in a Burkitt's lymphoma (8).
Recently, Boehm et al. (12) have analyzed the breakpoints of four independent cases
of the t(11;14) (p13;gll) in TALL. They found breakage adjoining a heptamer-like
sequence on chromosome 11 in only one case. However, the breakpoints of the
reciprocal translocation products were not sequenced. Overall, the number of trans-
location cases that have been analyzed in terms of both translocation products is
probably insufficient to allow a definite conclusion regarding the generality of a re-
combinase-mediated mechanism.
Of the two alternative hypotheses for the mechanism of chromosomal transloca-
tion in lymphoid neoplasms, recombinase-mediated translocation versus random
breakage, our data bearing on the t(7;9) (g34;g32) translocation strongly favor the
former. All three independent examples of the t(7;9) (834;32) translocation show
a junction with chromosome 9 DNA 5' to a TCR-(3 J region in the der(9) productTYCKO ET AL.
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and 3' to a D region in the der(7) product, consistent with translocation having oc-
curred by aberrant attempts at D-J joining. We find that all three cases possess break-
points within a narrowly defined region in chromosome 9 DNA between two closely
spaced perfect consensus heptamers. There are no directly repeated target sequences
which might suggest staggered breakage. Variablejunctionaldeletions and N-insertions
are present, characteristic ofrecombinase activity. All of these features provide strong
circumstantial evidence for the existence of a t(7;9) (g34;g32) translocation mecha-
nism involving targeted recombinase-mediated breakage on both chromosomes.
However, while consistent chromosomal breakage between consensus heptamer
sequences in the t(7 ;9) (g34 ;g32) ofTALL suggests a mechanism for chromosomal
recombination, it does not explain why cells carrying this translocation are leukemac.
What factors govern the presumptive growth advantage of these cells, such as struc-
tural or regulatory alteration of genes closely linked to translocation breakpoints,
remain to be determined.
Summary
Chromosomal translocations in lymphoid tumors frequently result from recom-
bination between a normally rearranging antigen receptor gene and a normally non-
rearranging second locus. The possibility that the lymphocyte recombinase apparatus
plays a role in determining the position of breakage at the second locus has been
a matter of controversy because of the inconsistent presence of heptamer-like recog-
nition sequences adjoining breakpoints at this site. To further investigate this issue,
sites of DNA recombination were analyzed in both the der(9) and der(7) products
oft(7 ;9) (g34;g32), a recurrent translocation of human acutelymphoblastic leukemias
(TALL). In each of three separate cases, the translocation has divided the TCR-~
locus, juxtaposing chromosome 9 DNA 5' to a J-region in the der(9) product and
3' to a D-region in the der(7) product, with variably sized N-insertions and small
deletions detectable at the junctions. All three cases contain breakpoints in chromo-
some 9 DNA tightly clustered between two closely spaced, and oppositely oriented
heptamer sequences, CAC(A/T)GTG, which perfectly match the consensus hep-
tamer sequence recognized by the lymphocyte recombinase apparatus in normal
antigen receptor gene rearrangement . In no case was there evidence ofdirectly dupli-
cated sequences in the two reciprocal products, as is often associated with recombi-
nation involving random staggered breakage of DNA . Taken together, these results
support a mechanism for this particular translocation proceeding by recombinase-
mediated breakage of both participating chromosomes.
Receivedfor publication 16 August 1988 and in revisedform 17 October 1988.
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